| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/16/2008 | WO2008060393A3 The use of materials and external stimuli for synovectomy |
| 10/16/2008 | WO2008058125A3 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 10/16/2008 | WO2008048288A3 Novel nanoparticles and use thereof |
| 10/16/2008 | WO2008046625A3 Encapsulation of heat and moisture sensitive substances |
| 10/16/2008 | WO2008046407A3 Use of deuterium dioxide for treating hyperproliferative skin diseases |
| 10/16/2008 | WO2008045373A3 Stable antibody formulations |
| 10/16/2008 | WO2008039291A3 Dosage forms for tamper prone therapeutic agents |
| 10/16/2008 | WO2008038147A3 Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof |
| 10/16/2008 | WO2008027442A3 Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use |
| 10/16/2008 | WO2008024490A3 Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use |
| 10/16/2008 | WO2008021234A3 Methods and compositions for needleless delivery of particles |
| 10/16/2008 | WO2008020421A3 Compositions comprising calcium citrate malate and methods for making the same |
| 10/16/2008 | WO2008018892A3 Methods and kits for treating lacerations and puncture wounds using inverse thermosensitive polymers |
| 10/16/2008 | WO2008016664A3 Compositions and methods for treating cancer with dacarbazine nanoemulsions |
| 10/16/2008 | WO2008014175A3 Granular pharmaceutical compositions |
| 10/16/2008 | WO2008011125A3 Devices, systems and methods for ophthalmic drug delivery |
| 10/16/2008 | WO2007143290A3 Delayed-release compositions of extended release forms of venlafaxine |
| 10/16/2008 | WO2007135362A3 Stable aqueous suspension having palatable taste |
| 10/16/2008 | WO2007121356A3 Method of treatment with predictably breakable pharmaceutical tablets |
| 10/16/2008 | WO2007112046A3 Alkylene-dicarboxylate-containing biodegradable poly(ester amides) and methods of use |
| 10/16/2008 | WO2007108010A8 Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate |
| 10/16/2008 | WO2007101224A3 Inhibitors of the unfolded protein response and methods for their use |
| 10/16/2008 | WO2007092646A3 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| 10/16/2008 | WO2007014073A3 Concentrated protein lyophilates, methods, and uses |
| 10/16/2008 | US20080255707 Method and system for categorizing blood glucose tests at test time in a portable device or later in a downloading program and then analyzing the categories separately |
| 10/16/2008 | US20080255643 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 10/16/2008 | US20080255557 High strength suture with absorbable core and suture anchor combination |
| 10/16/2008 | US20080255537 Biocompatible nanoparticle compositions and methods |
| 10/16/2008 | US20080255365 Microparticulate form of a Tetrahydropyridine derivative |
| 10/16/2008 | US20080255247 Droplets exhibit a nano-sized self-assembled structurization, a diameter size of 0.5 to 200 nm; a lipophilic additive, an active element; solubilizing nutrients, drugs, aromas or chemicals |
| 10/16/2008 | US20080255235 Inhibitor of a Levodopa-metabolising enzyme, a buffer, a sugar, an acid; Parkinson's disease |
| 10/16/2008 | US20080255227 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nonane-8-one-7-yl]heptanoic acid and a glyceride; improved stability |
| 10/16/2008 | US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders |
| 10/16/2008 | US20080255125 Topically Applied Medicament for Animals |
| 10/16/2008 | US20080255104 Nsaid Compositions |
| 10/16/2008 | US20080254134 Controlled release antigen delivery, entrapped or encapsulated within a biodegradable polymer particles, which is a copolymer of glycolic acid and lactic acid; vaccination against B. pertussis, inducing T cell proliferation, treating respiratory system disorders |
| 10/16/2008 | US20080254133 Microgel Particle |
| 10/16/2008 | US20080254132 stable antibodies dry powders consisting of monoclonal antibody and sucrose, threhalose, and mannitol; influenza virus instead of antibodies; viability, controlled particle size; storage stability, long shelf life without undue aggregation; used as therapeutics, nutrients, vaccines, pharmaceuticals |
| 10/16/2008 | US20080254131 core comprising a water insoluble polymer and acetylcholinesterase inhibitor, a release rate controlling coatings is surrounding the core including a release retarding excipient; administered less frequently, provide more stable blood levels; improve pharmacokinetic; dementia, mania, nicotine dependence |
| 10/16/2008 | US20080254130 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction |
| 10/16/2008 | US20080254129 Use of avian anti-methanogen antibodies for reduction of methane production |
| 10/16/2008 | US20080254128 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| 10/16/2008 | US20080254127 Inhalation particles incorporating a combination of two or more active ingredients |
| 10/16/2008 | US20080254126 health food and drink contains the pure plant extract, is for patients with abnormality in cerebral blood flow and metabolism of brain disorder; nutraceuticals; free of proanthocyanidins |
| 10/16/2008 | US20080254125 extruding an acylchitosan hydrogel from a biopolymer; fix in a desired shape on a tubular medical device as stent, catheter, vascular graft, nerve guide, or drainage tube; injectable including a therapeutic agent; mechanical strength and shape-memory stability; biocompatibility, biodegradability |
| 10/16/2008 | US20080254124 Controlled release composition |
| 10/16/2008 | US20080254123 Morphine polymer release system |
| 10/16/2008 | US20080254122 Controlled release for therapy, prophylaxis, diagnosis by erosion in aqueous solution; carvedilol; eliminates water diffusion between the interface between the polymer crystals; polyethylene glycol, polypropylene oxide and a block copolymer of ethylene oxide and propylene oxide |
| 10/16/2008 | US20080254121 sustained release dosage form has first-layer, second-layer and inner-core containing different amounts of melatonin; controlled release for sleep; improve sleep quality, treating insomnia |
| 10/16/2008 | US20080254120 Orally-disintegrating tablet and manufacturing method thereof |
| 10/16/2008 | US20080254119 nutritional supplement tablet comprises an oily liquid Vitamin E finely dispersed in an oil insoluble material; providing lubrication; free of magnesium stearate, free of undesirable problem; increase bonding, compressibility and tablet hardness |
| 10/16/2008 | US20080254118 Process for preparing pramipexole dihydrochloride tablets |
| 10/16/2008 | US20080254117 Process for preparing pramipexole dihydrochloride tablets |
| 10/16/2008 | US20080254116 Delta and Epsilon Crystal Forms of Imatinib Mesylate |
| 10/16/2008 | US20080254115 Arcuate surface structure; matrix release characteristics; capable of high dosage delivery; usable for sustained, pulsatile, enteric and immediate release drug formulations |
| 10/16/2008 | US20080254114 Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles |
| 10/16/2008 | US20080254113 Microemulsion Formulations Comprising Particular Substance P Antagonists |
| 10/16/2008 | US20080254112 Pharmaceutical Active-Ingredient-Containing Formulation with Coating |
| 10/16/2008 | US20080254111 Vinyl alcohol polymer; nonleaking; preventing oxygen and water entry |
| 10/16/2008 | US20080254110 Composition For Enhancing Immunity and Reducing Inflammation Related to Infections |
| 10/16/2008 | US20080254109 Delivering therapeutic nucleic acid into adjacent normal heart tissue; inducing angiogenesis and collateral blood vessel formation |
| 10/16/2008 | US20080254108 Formulations and Methods for Modulating Satiety |
| 10/16/2008 | US20080254107 Transdermal absorbtion and/or adsorbtion removal of inflammatory body fluids; such as dextrin, crushed tourmaline, chitosan and sorbic acid; skin patches |
| 10/16/2008 | US20080254106 Using antidepressant drug 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino[3,2,1-jk]carbazole (pirlindole) in combination with other active agents; topical delivery |
| 10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 10/16/2008 | US20080254104 Advanced functional biocompatible polymeric matrix containing nano-compartments |
| 10/16/2008 | US20080254102 Orally administered agent and an orally administered agent/supporting substrate complex |
| 10/16/2008 | US20080254101 Pilocarpine compositions and methods of use thereof |
| 10/16/2008 | US20080254100 Producing blunted postprandial glycemic response; using nutritional meal replacements that are rapidly metabolized and absorbed in small intestine; reducing body weight |
| 10/16/2008 | US20080254096 Using polyvinyl alcohol free biodegradable polymer matrix; reducing side effects, invasive procedures and high transient concentrations; glaucoma, proliferative vitreoretinopathy |
| 10/16/2008 | US20080254093 Compositions and minimally invasive methods for treating dysfunction of cardiac muscle |
| 10/16/2008 | US20080254090 Porcine Islets Cultured With Porcine Sertoli Cells For Xenotransplantation |
| 10/16/2008 | US20080254079 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology |
| 10/16/2008 | US20080254078 Simple, binary system of hydrophilic nanoparticles using cationic chitosan and anionic polysaccharides having carboxymethyl groups and/or sulfate groups; adjustable zeta potential of aqueous colloidal suspensions; binding biological groups covalently; drug delivery; foods; cosmetics; biocompatability |
| 10/16/2008 | US20080254077 Core/shell particles based on silicone compounds |
| 10/16/2008 | US20080254073 Transdermal Patch Comprising Paroxetine |
| 10/16/2008 | US20080254066 Emulsion comprising an aqueous phase, an oil phase, and a solvent and an immunogen |
| 10/16/2008 | US20080253998 Treatment of cancer using tlr3 agonists |
| 10/16/2008 | US20080253993 Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope |
| 10/16/2008 | US20080253974 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benz(enesulfon)amide and a second cooling agent, such as menthol or a derivative; similar cooling intensity to N-ethyl p-menthanecarboxamide (WS-3); ingestible or topical |
| 10/16/2008 | US20080253973 Sensation modifying topical composition foam |
| 10/16/2008 | US20080253971 Particles for inhalation having sustained release properties |
| 10/16/2008 | US20080253970 Stable Pharmaceutical Drug Products |
| 10/16/2008 | US20080253961 Drug delivery; biocompatable polyesters; biodegradable glycolic acid-lactic acid nanoshell (PLGA); controlled release |
| 10/16/2008 | US20080251615 Drug activation process and vibrational mill therefor |
| 10/16/2008 | DE202008010089U1 Exakt teilbare Filmtablette Exactly divisible tablet |
| 10/16/2008 | DE102007017435A1 Cosmetic preparation, useful as e.g. cosmetic light protection cream, day or night cream, comprises combination of 2-propyl heptyl octanoate and salicylate |
| 10/16/2008 | DE102007017434A1 Cosmetic preparation, useful as e.g. cosmetic light protection-, day- or night-cream, comprises a combination of 2-propyl heptyl octanoate, cetearyl alcohol, sodium cetearyl sulfate and glyceryl stearate |
| 10/16/2008 | CA2683611A1 Novel stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof |
| 10/16/2008 | CA2683415A1 An oral pharmaceutical composition |
| 10/16/2008 | CA2683409A1 A pharmaceutical composition of tacrolimus |
| 10/16/2008 | CA2683407A1 Pharmaceutical cyclosporin compositions |
| 10/16/2008 | CA2683063A1 Self-assembling nanoparticle drug delivery system |
| 10/16/2008 | CA2682872A1 Rapid dissolution of combination products |
| 10/16/2008 | CA2682822A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same |
| 10/16/2008 | CA2682752A1 Rapidly dissolving pharmaceutical compositions comprising pullulan |
| 10/16/2008 | CA2682507A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| 10/16/2008 | CA2681143A1 Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent |
| 10/16/2008 | CA2680329A1 Pharmaceutical formulations of ghrh molecules |
| 10/16/2008 | CA2679551A1 Stable aqueous g-csf formulations |